PFAS Linked to Lower Child Bone Density
Analysis based on 12 articles · First reported Mar 17, 2026 · Last updated Mar 21, 2026
The study's findings on PFAS (PFAS) and child bone health could negatively impact companies producing or using these chemicals, potentially leading to increased regulatory pressure and consumer avoidance. This may drive innovation towards safer alternatives and create opportunities for companies in the 'green' chemical sector.
A new study published in the Journal of the Endocrine Society, led by Dr. Jessie P. Buckley of the University of North Carolina at Chapel Hill, links early-life exposure to 'forever chemicals' known as PFAS (PFAS) to lower bone density in adolescents. Specifically, Perfluorooctanoic acid (PFOA) was consistently associated with reduced forearm bone density. The research, funded by the United States===National Institute of Environmental Health Sciences, suggests that PFAS may interfere with hormonal pathways and stem cell development, potentially increasing the risk of fractures and osteoporosis later in life. The study highlights the importance of reducing PFAS exposure, especially during critical developmental periods, and calls for further long-term research.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard